Fosun International Reports Strong First-Half Profit Growth for 2026
On July 29, 2026, Fosun International (00656.HK) issued a positive profit alert indicating that its net profit attributable to owners of the parent company in the first half of 2026 is expected to range between RMB1.5 billion and RMB1.8 billion. This represents an increase of approximately 127% to 172% compared to the same period last year, driven by strong performance across its core industries. The company's Health segment saw Fosun Pharma achieve operating revenue of RMB10.073 billion in Q1 2026 and a net profit increase of 13.87%. The Wealth segment showed robust growth with Pramerica Fosun Life Insurance reporting a net profit exceeding its full-year 2025 results, while the Happiness and Intelligent Manufacturing segments also reported significant year-on-year gains. Analysts attribute this performance to Fosun's strategy of streamlining operations and focusing on core businesses. The company has been exiting non-core assets and strengthening investments in key areas, laying a solid foundation for earnings recovery and long-term profitability.
Topics: financial performance insurance pharmaceuticals tourism